南予医誌 Vol.14 No. １ 2013－8－Usefulness of serum cystatin C measurement Takafumi OKURA Department of Cardiology, Pulmonology, Hypertension and Nephrology Ehime University School of Medicine Shitsukawa, Toon, Ehime 791-0295, JAPAN（Nan-yo Med J 2013；14：1-8.）10） Watanabe S, Okura T, Liu J, et al.: Serum cystatin C level is a marker of end-organ damage in patients with es-sential hypertension. Hypertens Res. 2003; 26: 895-899.11） Jernberg T, Lindahl B, James S, et al.: Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syn-drome. Circulation. 2004; 110: 2342-2348.12） Shlipak MG, Sarnak MJ, Katz R, et al.: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.13） Shlipak MG, Katz R, Sarnak MJ, et al.: Cystatin C and prognosis for cardio-vascular and kidney outcomes in el-derly persons without chronic kidney disease. Ann Intern Med 2006; 145: 237-246.14） Okura T, Jotoku M, Irita J, et al.: As-sociation between cystatin C and in-flammation in patients with essential hypertension. Clin Exp Nephrol 2010; 14: 584-588.
元のページ ../index.html#10